HCA Healthcare, Inc. (NYSE:HCA) Stock Holdings Lifted by Nordea Investment Management AB

Nordea Investment Management AB raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 29.7% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 843,764 shares of the company’s stock after buying an additional 193,075 shares during the quarter. Nordea Investment Management AB’s holdings in HCA Healthcare were worth $253,020,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Benjamin F. Edwards & Company Inc. bought a new position in shares of HCA Healthcare in the second quarter worth $33,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare in the third quarter valued at $39,000. Canoe Financial LP purchased a new position in HCA Healthcare in the 3rd quarter worth about $41,000. Capital Performance Advisors LLP purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $41,000. Finally, Northwest Investment Counselors LLC acquired a new stake in shares of HCA Healthcare in the third quarter worth $44,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on HCA. Oppenheimer upped their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. Barclays reduced their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research report on Friday, November 8th. TD Cowen cut their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Morgan Stanley lowered their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Finally, Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $391.27.

HCA Healthcare Trading Down 0.4 %

NYSE HCA opened at $296.70 on Monday. The stock’s 50-day moving average is $326.93 and its 200-day moving average is $354.99. HCA Healthcare, Inc. has a one year low of $271.13 and a one year high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm has a market cap of $75.15 billion, a P/E ratio of 13.32, a P/E/G ratio of 1.21 and a beta of 1.64.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a dividend of $0.66 per share. The ex-dividend date was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.89%. HCA Healthcare’s payout ratio is 11.85%.

Insider Buying and Selling

In other news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.